Description

Co-Amlessa (perindopril tert-butylamine, indapamide, amlodipine) tablets 4 mg/1.25 mg/5 mg. №30

Ingredients

Active ingredients: Perindopril tert-butylamine, Indapamide, Amlodipine.

Dosage

Recommended dosage: One tablet daily, or as prescribed by a healthcare professional.

Indications

Indicated for: Hypertension and related conditions.

Contraindications

Do not use if: Allergic to any of the ingredients, pregnant, or breastfeeding.

Directions

Directions for use: Take the tablet with water, with or without food, at the same time each day.

Scientific Evidence

Pharmacological effects: Co-Amlessa combines the antihypertensive properties of perindopril, indapamide, and amlodipine to effectively lower blood pressure. Perindopril inhibits ACE, indapamide is a diuretic, and amlodipine is a calcium channel blocker, acting synergistically to manage hypertension.

Clinical trials: Clinical studies have demonstrated the efficacy of Co-Amlessa in reducing blood pressure levels and improving overall cardiovascular health. Research by XYZ et al. (Year) showed a significant decrease in systolic and diastolic blood pressure with the use of this combination therapy.

Additional Information

Warnings: It is important to monitor blood pressure regularly while using Co-Amlessa. Consult a healthcare provider before starting or changing the dosage.

Storage: Store in a cool, dry place away from direct sunlight. Keep out of reach of children.